Transgender CEO speaks out on NC's HB2

Transgender CEO Martine Rothblatt of United Therapeutics speaks about House Bill 2 and the transgender controversy surrounding North Carolina's House Bill 2.
Up Next
Transgender CEO Martine Rothblatt of United Therapeutics speaks about House Bill 2 and the transgender controversy surrounding North Carolina's House Bill 2.

For transgender CEO, fight to repeal NC’s HB2 is personal

May 13, 2016 04:48 PM